ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Symptoms of Schizophrenia

December 01, 2021

Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campaign to Bring Greater Awareness to Parkinson’s Disease Non-Motor Symptoms

November 16, 2021

Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results

November 08, 2021

Acadia Pharmaceuticals Presents New Dementia-Related Psychosis Real-World Outcomes Data at Psych Congress 2021

November 02, 2021

Acadia Pharmaceuticals Appoints Brendan Teehan, Executive Vice President, Chief Operating Officer, Head of Commercial

November 01, 2021

Acadia Pharmaceuticals to Announce Third Quarter 2021 Financial Results on November 8, 2021

October 27, 2021

Acadia Pharmaceuticals to Present Data on Pimavanserin in Patients with Parkinson’s Disease Dementia with Psychosis from the HARMONY trial at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

October 25, 2021

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

September 02, 2021

Acadia Pharmaceuticals Announces Executive Leadership Change

September 01, 2021

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Long Term Investor Notice: Investigation of Potential Wrongdoing ↗

August 25, 2021

San Diego, CA -- (SBWIRE) -- 08/25/2021 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of ACADIA Pharmaceuticals Inc.

Via SBWire

Topics Lawsuit

Acadia Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference on August 12, 2021

August 05, 2021

Acadia Pharmaceuticals Reports Second Quarter 2021 Financial Results

August 04, 2021

The New England Journal of Medicine Publishes Results from the Phase 3 HARMONY Study Evaluating Pimavanserin in Patients with Dementia-Related Psychosis

July 21, 2021

Acadia Pharmaceuticals to Announce Second Quarter 2021 Financial Results on August 4, 2021

July 21, 2021

Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer’s Association International Conference 2021 (AAIC)

July 14, 2021

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 21, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

June 20, 2021

From The Schall Law Firm

MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 19, 2021

From The Schall Law Firm

DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 18, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

June 17, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Topics Lawsuit

June 16, 2021

From Bragar Eagel & Squire, P.C.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

June 16, 2021

From The Law Offices of Frank R. Cruz

Two Days Left to Actively Participate in ACADIA Pharmaceuticals Inc. (ACAD) Class Action: Bronstein, Gewirtz & Grossman, LLC

June 16, 2021

From Bronstein, Gewirtz & Grossman, LLC

FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 16, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FRIDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

June 15, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

FRIDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Topics Lawsuit

June 14, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Topics Lawsuit

June 11, 2021

From Bragar Eagel & Squire, P.C.

ACAD BREAKING ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 18 Deadline in Securities Class Action – ACAD

June 11, 2021

From Rosen Law Firm

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

June 11, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.